NEVVI Medicare utilization intelligence
Compare this code with others
Market snapshot

Nationwide CY2023

Medicare Part B FFS · CY2023 · as published by CMS

Jump to the result views

G0141 Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician HCPCS · Anatomic Pathology test
Classification Test › Anatomic Pathology (CMS RBCS)
First observed 2013 — start of our 12-year window; the code predates it
National scale 4,551 services · est. ▲ 39.9% YoY · 2,306 FFS beneficiary-episodes (CY2024, all-Medicare estimate) — 2,316 observed fee-for-service services
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window

See it in full: sestamibi, the nuclear heart-imaging tracer (A9500), in Arizona is open as a live example — every paid panel, on real data.

View the live example →
Data year CY2024 CY2023 CY2022 locked column CY2021 locked column CY2020 locked column
Filter results:
Market summary
Market Brief G0141
A shareable PDF report summarizing this market’s size, trends, and providers.
Preview this Brief →

This market's Overview — its estimated all-Medicare volume, national benchmarks, and what the field charges and is paid — is part of Explore.

See what Medicare pays

An Explore subscription, $249 a seat a year, opens the Overview on every code, group and clinician page, including what the market charges and is paid.

It comes with 25 credits a seat a year for Deep Dives, which open the rest.

Subscribe to Explore →

View the live example →

Included in Explore. Part of a Deep Dive.
Continue from here